PVDOMICSPulmonary Vascular Disease Phenomics in Pulmonary Hypertension
This study observes and analyzes genetic and molecular data to better define and classify pulmonary vascular diseases in people with pulmonary hypertension.
Data Collection
Collected from today forward - ProspectivePulmonary Arterial Hypertension+1
+ Hypertension, Pulmonary
+ Lung Diseases
Cohort
Tracking disease incidence in order to identify risk factors and understand disease progression over time.Summary
Study start date: November 1, 2016
Actual date on which the first participant was enrolled.This study aims to improve our understanding of pulmonary hypertension, a condition affecting the blood vessels in the lungs, and right heart dysfunction. It focuses on analyzing patients based on their molecular and clinical features, as well as other detailed characteristics like blood flow and imaging results. The goal is to create new ways to classify these conditions by linking these detailed descriptions with specific molecular causes. This could help identify different types of lung vascular diseases and find new markers that could aid in early diagnosis or in assessing how well treatments are working. Participants in this study will undergo evaluations every six months, which include clinical assessments, a 6-minute walk test, heart imaging, and blood tests for various molecular analyses. The study will compare these findings over time to see how well they predict disease progress, changes in symptoms, response to treatment, and survival. By doing this, the research aims to develop precise definitions of pulmonary vascular diseases using advanced molecular data, which could lead to better diagnosis and treatment options.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.1195 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Cohort
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.From 18 to 100 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 7 locations
University of Arizona Health Sciences Center
Tucson, United StatesOpen University of Arizona Health Sciences Center in Google MapsJohns Hopkins University School of Medicine
Baltimore, United StatesBrigham and Women's Hospital
Boston, United StatesMayo Clinic
Rochester, United States